Omerez, Mei-ann A.
HRN: 22-15-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/08/2022
CEFUROXIME 500MG (TAB)
11/08/2022
11/14/2022
PO
1 Tab
BID
S/p NSVD W/ RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes